This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Australia, Canada, Chile, China, Denmark, Germany, Italy, Singapore, South Korea, Spain, Switzerland, the United Kingdom, and the United States.
This study is ongoing in the United Kingdom, in Germany, and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase for Schizophrenia.
This study is completed in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
This study is ongoing in the United Kingdom and in Poland. It is testing Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, for Schizophrenia.
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.